These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21243988)

  • 1. Respiratory syncytial virus infection in children.
    Dawson-Caswell M; Muncie HL
    Am Fam Physician; 2011 Jan; 83(2):141-6. PubMed ID: 21243988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis in RSV infection (Palivizumab)--is it worthwhile?
    Hashmi NA; Cosgrove JF; MacMahon P
    Ir Med J; 2000 Dec; 93(9):284. PubMed ID: 11209917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
    Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory syncytial virus infection in infants and young children.
    Levy BT; Graber MA
    J Fam Pract; 1997 Dec; 45(6):473-81. PubMed ID: 9420581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
    Simoes EA; Carbonell-Estrany X
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating acute bronchiolitis associated with RSV.
    Steiner RW
    Am Fam Physician; 2004 Jan; 69(2):325-30. PubMed ID: 14765771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and prevention strategies for respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a review of evidence-based practice interventions.
    Cooper AC; Banasiak NC; Allen PJ
    Pediatr Nurs; 2003; 29(6):452-6. PubMed ID: 14743842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.
    American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn
    Pediatrics; 2003 Dec; 112(6 Pt 1):1442-6. PubMed ID: 14654627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy.
    Bradley JP; Bacharier LB; Bonfiglio J; Schechtman KB; Strunk R; Storch G; Castro M
    Pediatrics; 2005 Jan; 115(1):e7-14. PubMed ID: 15629968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory Syncytial Virus Bronchiolitis in Children.
    Smith DK; Seales S; Budzik C
    Am Fam Physician; 2017 Jan; 95(2):94-99. PubMed ID: 28084708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis against respiratory syncytial virus in young children with cystic fibrosis.
    Giebels K; Marcotte JE; Podoba J; Rousseau C; Denis MH; Fauvel V; Laberge S
    Pediatr Pulmonol; 2008 Feb; 43(2):169-74. PubMed ID: 18085710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis.
    Heikkinen T; Valkonen H; Lehtonen L; Vainionpää R; Ruuskanen O
    Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F64-8. PubMed ID: 15613580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of respiratory syncytial virus infection in infants and young children referred to the emergency departments for lower respiratory tract diseases in Italy.
    Medici MC; Arcangeletti MC; Merolla R; Chezzi C;
    Acta Biomed; 2004 Apr; 75(1):26-33. PubMed ID: 15315084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of respiratory syncytial virus-related hospitalizations in high-risk children: follow-up of a national cohort of infants treated with Palivizumab as RSV prophylaxis.
    Lacaze-Masmonteil T; Rozé JC; Fauroux B;
    Pediatr Pulmonol; 2002 Sep; 34(3):181-8. PubMed ID: 12203846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus bronchiolitis.
    Jeng MJ; Lemen RJ
    Am Fam Physician; 1997 Mar; 55(4):1139-46, 1149-50. PubMed ID: 9092277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of respiratory syncytial virus infection as a cause of lower respiratory tract infection in children younger than 3 years of age in Japan.
    Kaneko M; Watanabe J; Kuwahara M; Ueno E; Hida M; Kinoshita A; Sone T
    J Infect; 2002 May; 44(4):240-3. PubMed ID: 12099731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory tract infections caused by respiratory syncytial virus in children. Diagnosis and treatment.
    Van Woensel JB; Kimpen JL; Brand PL
    Minerva Pediatr; 2001 Apr; 53(2):99-106. PubMed ID: 11404731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants.
    Pediatrics; 1998 Sep; 102(3):531-7. PubMed ID: 9724660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity.
    Lanari M; Giovannini M; Giuffré L; Marini A; Rondini G; Rossi GA; Merolla R; Zuccotti GV; Salvioli GP;
    Pediatr Pulmonol; 2002 Jun; 33(6):458-65. PubMed ID: 12001280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent wheezing after respiratory syncytial virus or non-respiratory syncytial virus bronchiolitis in infancy: a 3-year follow-up.
    Valkonen H; Waris M; Ruohola A; Ruuskanen O; Heikkinen T
    Allergy; 2009 Sep; 64(9):1359-65. PubMed ID: 19416146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.